Wednesday, February 10, 2010, 6:38am EST - Canadian Markets open in 2 hours and 52 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Eli Lilly & Co. (LLY)

On Feb 9: 35.20 USD   0.00 (0.00%)  
MORE ON LLY
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
LILLY ELI CO (NYSE:LLY) Delayed quote dataEdit
Last Trade: 35.20 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 34.71
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 58.50
Day's Range: N/A - N/A
52wk Range: 27.21 - 38.40
Volume: 0
Avg Vol (3m): 6,916,010
Market Cap: 40.45B
P/E (ttm): 17.20
EPS (ttm): 2.05
Div & Yield: 1.96 (5.65%)
Eli Lilly & Co. (LLY)
1d  5d  3m  6m  1y  2y  5y  max 
 Add LLY to Portfolio   Download Data

HEADLINES
Researchers find sex-specific lung cancer genes
at Reuters (Tue 7:34pm)
UK court overturns GSK patent for lupus drug
at FT.com (Tue 6:10pm)
Bone Up On This Potential Blockbuster
at Motley Fool (Tue 11:58am)
UK court rules HGS gene patent invalid -lawyers
at Reuters (Tue 11:39am)
Four Stock Ideas as the Market Searches for Support
at Seeking Alpha (Tue 9:56am)
Health Care: Rx for MBA Job Blues
BusinessWeek (Tue 8:08am)
Lechleiter pay rises in 1st full year as Lilly CEO
AP (Mon, Feb 8)
Eli Lilly CEO's 2009 Compensation Totaled $16.4 Million
at The Wall Street Journal Online (Mon, Feb 8)
Alkermes Retains Neutral Rec
Zacks.com (Mon, Feb 8)
[$$] Sanofi to decide soon on reviving Merck venture
at The Wall Street Journal Online (Sun, Feb 7)
How Big Pharma Got in This Fix
at Seeking Alpha (Sun, Feb 7)
[$$] Research Reports
at Barrons.com (Sat, Feb 6)
What Is The Value Of An Employee
at Investopedia (Fri, Feb 5)
Stalled Health Care Bill Leaves Drug Makers in Regulatory Limbo
at The New York Times (Fri, Feb 5)
More Headlines for LLY...

ANALYST
EPS Est (next year) (Dec-08) : 3.91
EPS Est (in 2 years) (Dec-09) : 4.31
Avg Rec (current)*: 2.8
PEG Ratio: 1.68
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Eli Lilly and Company engages in the discovery, development, manufacture, and sale of pharmaceutical products in the United States, Puerto Rico, and internationally.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices